Cargando…

Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017

BACKGROUND: Previous studies report increasing cholangiocarcinoma (CCA) incidence up to 2015. This contemporary retrospective analysis of CCA incidence and mortality in the US from 2001-2017 assessed whether CCA incidence continued to increase beyond 2015. PATIENTS AND METHODS: Patients (≥18 years)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Javle, Milind, Lee, Sunyoung, Azad, Nilofer S, Borad, Mitesh J, Kate Kelley, Robin, Sivaraman, Smitha, Teschemaker, Anna, Chopra, Ishveen, Janjan, Nora, Parasuraman, Shreekant, Bekaii-Saab, Tanios S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Hepatobiliary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526482/ https://www.ncbi.nlm.nih.gov/pubmed/35972334 http://dx.doi.org/10.1093/oncolo/oyac150

Ejemplares similares

Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors
por: Javle, Milind, et al.
Publicado: (2023)

Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland
por: Barner‐Rasmussen, Nina, et al.
Publicado: (2021)

Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
por: Saha, Supriya K., et al.
Publicado: (2016)

An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma
por: Madoff, David C, et al.
Publicado: (2022)

Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics
por: Silva, Mario, et al.
Publicado: (2021)

Textbook oncologic outcomes and regionalization among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma
por: Munir, Muhammad M., et al.
Publicado: (2022)

Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it’s not all about size
por: Kolck, Johannes, et al.
Publicado: (2023)

Nomogram based on MRI for preoperative prediction of Ki-67 expression in patients with intrahepatic mass cholangiocarcinoma
por: Chen, Xiang, et al.
Publicado: (2022)

Pemigatinib for adults with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions/rearrangements
por: Walden, Daniel, et al.
Publicado: (2022)

Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer
por: Abdel-Wahab, Reham, et al.
Publicado: (2020)

Staging Laparoscopy for Hilar Cholangiocarcinoma: Is it Still Worthwhile?
por: Ruys, Anthony T., et al.
Publicado: (2011)

Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma
por: Vugts, Jaynee J. A., et al.
Publicado: (2020)

Inflammatory myofibroblastic tumour of liver masquerading as hilar cholangiocarcinoma
por: Subash, R, et al.
Publicado: (2011)

Comparison of the Sixth and the Seventh Editions of the UICC Classification for Perihilar Cholangiocarcinoma
por: Juntermanns, Benjamin, et al.
Publicado: (2012)

Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma
por: Murugesan, Karthikeyan, et al.
Publicado: (2021)

A rare case of non-metastatic cholangiocarcinoma in a long standing choledochal cyst
por: Goukassian, ID, et al.
Publicado: (2012)

Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma
por: Andresen, Kim, et al.
Publicado: (2015)

Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma
por: Mantel, Hendrik T. J., et al.
Publicado: (2015)

Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases
por: Wiggers, Jimme K., et al.
Publicado: (2015)

Geographic Disparities in Referral Rates and Oncologic Outcomes of Intrahepatic Cholangiocarcinoma: A Population-Based Study
por: Sutton, Thomas L., et al.
Publicado: (2021)

The Influence of Hepatic Steatosis and Fibrosis on Postoperative Outcomes After Major Liver Resection of Perihilar Cholangiocarcinoma
por: van Keulen, Anne-Marleen, et al.
Publicado: (2023)

Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy
por: Coelen, Robert J. S., et al.
Publicado: (2016)

Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma
por: Olthof, Pim B., et al.
Publicado: (2020)

Total Laparoscopic Resection of Hilar Cholangiocarcinoma Type 3b: Applying a Parachute Technique for Hepaticojejunostomy
por: Sucher, Robert, et al.
Publicado: (2020)

Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
por: Holster, Jessica J., et al.
Publicado: (2022)

Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
por: Franssen, Stijn, et al.
Publicado: (2023)

COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry
por: Brozat, Jonathan F., et al.
Publicado: (2022)

Using Naïve Bayesian Analysis to Determine Imaging Characteristics of KRAS Mutations in Metastatic Colon Cancer
por: Pershad, Yash, et al.
Publicado: (2017)

Maintenance Therapy in First-Line Gastric and Gastroesophageal Junction Adenocarcinoma: A Retrospective Analysis
por: Walden, Daniel, et al.
Publicado: (2021)

Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group
por: Ruzzenente, Andrea, et al.
Publicado: (2021)

Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2
por: Liu, Runping, et al.
Publicado: (2014)

ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study
por: Li, Jun, et al.
Publicado: (2020)

The Long-Term Outcome of Laparoscopic Resection for Perihilar Cholangiocarcinoma Compared with the Open Approach: A Real-World Multicentric Analysis
por: Qin, Tingting, et al.
Publicado: (2022)

Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
por: Wang, Xiaolong, et al.
Publicado: (2020)

Extreme In Situ Liver Surgery Under Total Vascular Exclusion with Right Hepatic Vein and Inferior Vena Cava Grafts for an Intrahepatic Cholangiocarcinoma
por: Lopez-Lopez, Victor, et al.
Publicado: (2022)

A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features
por: Shen, Keren, et al.
Publicado: (2023)

Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: Sanoff, Hanna K., et al.
Publicado: (2016)

Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
por: Liu, Xiufeng, et al.
Publicado: (2019)

Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment‐Related Adverse Events From the CheckMate 040 Study
por: Julien, Karen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eief479mhcbst7t632r15cuuhl